FI832197A0 - Farmaceutisk blandning - Google Patents

Farmaceutisk blandning

Info

Publication number
FI832197A0
FI832197A0 FI832197A FI832197A FI832197A0 FI 832197 A0 FI832197 A0 FI 832197A0 FI 832197 A FI832197 A FI 832197A FI 832197 A FI832197 A FI 832197A FI 832197 A0 FI832197 A0 FI 832197A0
Authority
FI
Finland
Prior art keywords
blanding
pharmaceutical
pharmaceutical blanding
Prior art date
Application number
FI832197A
Other languages
English (en)
Other versions
FI85213C (fi
FI85213B (fi
FI832197L (fi
Inventor
Anders Goeran Vilh Kaellstrand
Kjell Johan Mattsson
Rolf Ivar Sjoeqvist
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of FI832197A0 publication Critical patent/FI832197A0/fi
Publication of FI832197L publication Critical patent/FI832197L/fi
Application granted granted Critical
Publication of FI85213B publication Critical patent/FI85213B/fi
Publication of FI85213C publication Critical patent/FI85213C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
FI832197A 1982-06-24 1983-06-16 Foerfarande foer framstaellning av en farmaceutisk beredning. FI85213C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8203953 1982-06-24
SE8203953A SE8203953D0 (sv) 1982-06-24 1982-06-24 Pharmaceutical mixture

Publications (4)

Publication Number Publication Date
FI832197A0 true FI832197A0 (fi) 1983-06-16
FI832197L FI832197L (fi) 1983-12-25
FI85213B FI85213B (fi) 1991-12-13
FI85213C FI85213C (fi) 1992-03-25

Family

ID=20347191

Family Applications (1)

Application Number Title Priority Date Filing Date
FI832197A FI85213C (fi) 1982-06-24 1983-06-16 Foerfarande foer framstaellning av en farmaceutisk beredning.

Country Status (29)

Country Link
EP (1) EP0101418B1 (fi)
JP (1) JPS5916822A (fi)
KR (1) KR910000028B1 (fi)
AR (1) AR231075A1 (fi)
AT (1) ATE59286T1 (fi)
AU (1) AU561954B2 (fi)
BG (1) BG51341A3 (fi)
CA (1) CA1214726A (fi)
CS (1) CS257769B2 (fi)
CY (1) CY1468A (fi)
DD (1) DD209971A5 (fi)
DE (1) DE3382086D1 (fi)
DK (1) DK161365C (fi)
ES (1) ES8403720A1 (fi)
FI (1) FI85213C (fi)
GB (1) GB2122490B (fi)
GR (1) GR78604B (fi)
HK (1) HK98786A (fi)
HU (1) HU189300B (fi)
IE (1) IE55204B1 (fi)
IS (1) IS1325B6 (fi)
MY (1) MY8700292A (fi)
NO (1) NO168745C (fi)
NZ (1) NZ204639A (fi)
PH (1) PH21911A (fi)
PT (1) PT76919B (fi)
SE (1) SE8203953D0 (fi)
SU (1) SU1722207A3 (fi)
ZA (1) ZA833931B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0729927B2 (ja) * 1983-04-09 1995-04-05 日研化学株式会社 テオフィリン徐放性製剤
SE8405611D0 (sv) * 1984-11-09 1984-11-09 Astra Laekemedel Ab Process for stabilization of bacampicillin hydrochloride
IT1183575B (it) * 1985-05-08 1987-10-22 Eurand Spa Formulazione deodorando ad effetto modulante sulla trfaspirazione
NL8503539A (nl) * 1986-01-02 1987-07-16 Warner Lambert Co Sucrose-vrije preparaten.
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
US4874613A (en) * 1987-03-06 1989-10-17 Baker Cummins Pharmaceuticals, Inc. Taste concealing pharmaceutical dosage unit
US5427935A (en) * 1987-07-24 1995-06-27 The Regents Of The University Of Michigan Hybrid membrane bead and process for encapsulating materials in semi-permeable hybrid membranes
SE463542B (sv) * 1987-08-31 1990-12-10 Lejus Medical Ab Granulaer instanticerbar produkt samt foerfarande foer dess framstaellning
WO1989010117A1 (en) * 1988-04-19 1989-11-02 Southwest Research Institute Controlled release of active ingredients from capsules having a salt sensitive shell material
US5064650A (en) * 1988-04-19 1991-11-12 Southwest Research Institute Controlled-release salt sensitive capsule for oral use and adhesive system
FR2653337B1 (fr) * 1989-10-23 1992-02-07 Dow Corning Sa Element a liberation prolongee et procede pour le fabriquer.
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
US5364634A (en) * 1991-11-08 1994-11-15 Southwest Research Institute Controlled-release PH sensitive capsule and adhesive system and method
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
JP3265680B2 (ja) * 1992-03-12 2002-03-11 大正製薬株式会社 経口製剤用組成物
DE4312656C2 (de) * 1993-04-19 1996-01-25 Beiersdorf Ag Kühlend wirkende kosmetische oder dermatologische Zusammensetzungen
DE4423078B4 (de) * 1994-07-01 2005-01-13 Awd.Pharma Gmbh & Co. Kg Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
CN1170596C (zh) * 1995-05-02 2004-10-13 大正制药株式会社 口服用组合物
DE19706978A1 (de) * 1997-02-21 1998-08-27 Ulrich Dr Posanski Kombinationspräparat für oral applizierbare Antibiotika
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL297088A (fi) * 1961-01-31
US3689654A (en) * 1970-09-14 1972-09-05 Morton Norwich Products Inc Pharmaceutical compositions
JPS50126822A (fi) * 1974-02-22 1975-10-06
SE8003805L (sv) * 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
US4321253A (en) * 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
JPS57209223A (en) * 1981-06-19 1982-12-22 Tanabe Seiyaku Co Ltd Microcapsule for intracranial anti hypotension and its production

Also Published As

Publication number Publication date
IE55204B1 (en) 1990-07-04
DE3382086D1 (de) 1991-02-07
AR231075A1 (es) 1984-09-28
CY1468A (en) 1989-07-21
EP0101418A2 (en) 1984-02-22
NO168745B (no) 1991-12-23
JPH0559089B2 (fi) 1993-08-30
CS463683A2 (en) 1987-11-12
KR840005024A (ko) 1984-11-03
PT76919B (en) 1986-04-09
GB2122490B (en) 1986-04-03
DK272383D0 (da) 1983-06-14
BG51341A3 (en) 1993-04-15
DK272383A (da) 1983-12-25
SE8203953D0 (sv) 1982-06-24
FI85213C (fi) 1992-03-25
SU1722207A3 (ru) 1992-03-23
ES523536A0 (es) 1984-04-01
GB2122490A (en) 1984-01-18
JPS5916822A (ja) 1984-01-28
ATE59286T1 (de) 1991-01-15
PT76919A (en) 1983-07-01
HU189300B (en) 1986-06-30
CS257769B2 (en) 1988-06-15
AU561954B2 (en) 1987-05-21
GB8317071D0 (en) 1983-07-27
PH21911A (en) 1988-04-08
KR910000028B1 (ko) 1991-01-19
DK161365B (da) 1991-07-01
EP0101418A3 (en) 1984-11-14
IS1325B6 (is) 1988-08-03
FI85213B (fi) 1991-12-13
DK161365C (da) 1991-12-09
FI832197L (fi) 1983-12-25
NZ204639A (en) 1986-01-24
EP0101418B1 (en) 1990-12-27
IS2824A7 (is) 1983-12-25
IE831462L (en) 1983-12-24
MY8700292A (en) 1987-12-31
HK98786A (en) 1986-12-24
DD209971A5 (de) 1984-05-30
NO832293L (no) 1983-12-27
AU1594383A (en) 1984-01-05
GR78604B (fi) 1984-09-27
CA1214726A (en) 1986-12-02
ZA833931B (en) 1984-07-25
ES8403720A1 (es) 1984-04-01
NO168745C (no) 1992-04-01

Similar Documents

Publication Publication Date Title
FI822191L (fi) Farmaceutisk blandning
NO831186L (no) Fortilsetning for droevtyggere
FI831749A0 (fi) Raffinerad avgiftad endotoxinprodukt
FI833347A0 (fi) Fjaerrstyrd underhaolls- och kontrolltransportoer
FI832197L (fi) Farmaceutisk blandning
DK345682A (da) Pharmaceutiske expienser
FI833638A0 (fi) Central loepbandsenhet foer funktioner
FR2527098B1 (fr) No
FI833594A0 (fi) Skidsko
BR8301654A (pt) Corantes dis - e tris - azoicos
IT1163627B (it) Voltagraticcio singolo
FI830792A0 (fi) Kabelklaemma
FI831687L (fi) Farmaceutiska blandningar vilka innehaoller flere aktiva bestaondsdelar
DK314283D0 (da) Farmaceutiske praeparater
NO823988L (no) Insekticid blanding
FI823462A0 (fi) Barnvagn
BE894865A (fr) Biertransportwagen
ATA154482A (de) Skoliosemieder
FI833332A (fi) Uppbaerningsanordning
AT373020B (de) Ruestungstraeger
ATA468282A (de) Drehrohrofen
ATA441982A (de) Hypsometer
BR6200972U (pt) Elementos
BR6201568U (pt) Elementos
AR226015A1 (es) Catre-reposera

Legal Events

Date Code Title Description
MA Patent expired

Owner name: ASTRA LAEKEMEDEL AKTIEBOLAG